API | 111in-j591

111in-j591 Report issue

Biologics mAb Imaging Experimental

AACT ChEMBL

Active Ingredient History

NOW

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules:

j591

mu-j591

j591 177lu

huj591 111in

huj591 177lu

More Chemistry

Pharmacology

Mechanisms of Action:
- Glutamate carboxypeptidase 2 (Homo sapiens) ^UniProt
- Glutamate carboxypeptidase 2 (Homo sapiens) ^UniProt
Multi-specific: No
Imaging: 111-indium
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

111in-j591 | 117lu-j591 | 177 lu-j591 | 177lu -j591 | 177lu-j591 | huj591 | huj591 (111in) | huj591 (177lu) | huj591-gs | j591 | j591 177lu | muj591 | mu-j591

Organizations (3)

Research & Development (3)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (1)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (1)

Prostatic Neoplasms (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 10
# of Trial Organizations: 3

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue